ReviewCurrent treatment options in cardiovascular medicine2026
Exercise and Sport Participation in Pediatric Hypertrophic Cardiomyopathy: A Changing Paradigm.
Review in Current treatment options in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose of Review: This review aims to detail recent research and guidelines that have changed the approach to exercise and sport participation in the pediatric hypertrophic cardiomyopathy (HCM) population. Recent Findings: Recent studies, including the landmark LIVE-HCM cohort, demonstrated that vigorous exercise was not associated with death, implantable cardiac defibrillator (ICD) shock, resuscitated cardiac arrest, or arrhythmic syncope in patients with HCM. Furthermore, there is increasing evidence that restriction from physical activity (PA) has negative consequences for the cardiovascular health and emotional well-being of children with HCM. This has influenced guidelines that promote individualized risk assessment and shared decision-making (SDM), rather than uniform restriction, in children with HCM who wish to participate in both recreational and competitive athletics. Summary: The relationship between PA and cardiac events in children and adults with HCM is more nuanced than once believed, and the negative consequences of uniform PA restrictions have become increasingly clear. Guided by recent prospective cohort studies, the approach to adolescents and young adults with HCM is changing, now emphasizing the role of individualized risk assessment and SDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.